Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

Phase 2

3(60.0%)

Phase 3

1(20.0%)

Early Phase 1

1(20.0%)

5Total

Phase 2(3)

Phase 3(1)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02437851Phase 2Completed

Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

Role: collaborator

NCT03284866Phase 3Completed

HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV

Role: collaborator

NCT03077451Phase 2Completed

Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma

Role: collaborator

NCT04139304Early Phase 1Recruiting

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Role: collaborator

NCT01567722Terminated

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Role: collaborator

NCT01209325Phase 2Completed

Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males

Role: collaborator

All 6 trials loaded